These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26344594)

  • 1. Biological activity of N(4)-boronated derivatives of 2'-deoxycytidine, potential agents for boron-neutron capture therapy.
    Nizioł J; Uram Ł; Szuster M; Sekuła J; Ruman T
    Bioorg Med Chem; 2015 Oct; 23(19):6297-304. PubMed ID: 26344594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, reactivity and biological activity of N(4)-boronated derivatives of 2'-deoxycytidine.
    Nizioł J; Zieliński Z; Leś A; Dąbrowska M; Rode W; Ruman T
    Bioorg Med Chem; 2014 Aug; 22(15):3906-12. PubMed ID: 24999002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
    Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
    Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
    Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1339-43. PubMed ID: 24508130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N(4)-[B-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan)methyl]-2'-deoxycytidine as a potential boron delivery agent with respect to glioblastoma.
    Uram Ł; Nizioł J; Maj P; Sobich J; Rode W; Ruman T
    Biomed Pharmacother; 2017 Nov; 95():749-755. PubMed ID: 28888921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron in cancer therapeutics: An overview.
    Kulkarni S; Bhandary D; Singh Y; Monga V; Thareja S
    Pharmacol Ther; 2023 Nov; 251():108548. PubMed ID: 37858628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents.
    Kaniowski D; Ebenryter-Olbińska K; Sobczak M; Wojtczak B; Janczak S; Leśnikowski ZJ; Nawrot B
    Molecules; 2017 Aug; 22(9):. PubMed ID: 28832537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT).
    Wittig A; Michel J; Moss RL; Stecher-Rasmussen F; Arlinghaus HF; Bendel P; Mauri PL; Altieri S; Hilger R; Salvadori PA; Menichetti L; Zamenhof R; Sauerwein WA
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):66-90. PubMed ID: 18439836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
    Cai J; Hosmane NS; Takagaki M; Zhu Y
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy.
    Kabalka GW; Shaikh AL; Barth RF; Huo T; Yang W; Gordnier PM; Chandra S
    Appl Radiat Isot; 2011 Dec; 69(12):1778-81. PubMed ID: 21481596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of a novel functionalized azanonaborane cluster for boron neutron capture therapy.
    Genady AR
    Org Biomol Chem; 2005 Jun; 3(11):2102-8. PubMed ID: 15917896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.
    Crossley EL; Ziolkowski EJ; Coderre JA; Rendina LM
    Mini Rev Med Chem; 2007 Mar; 7(3):303-13. PubMed ID: 17346220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron-containing protoporphyrin IX derivatives and their modification for boron neutron capture therapy: synthesis, characterization, and comparative in vitro toxicity evaluation.
    El-Zaria ME; Ban HS; Nakamura H
    Chemistry; 2010 Feb; 16(5):1543-52. PubMed ID: 20020518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boronated carbohydrate derivatives as potential boron neutron capture therapy reagents.
    Marepally SR; Yao ML; Kabalka GW
    Future Med Chem; 2013 Apr; 5(6):693-704. PubMed ID: 23617431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).
    Nakase I; Katayama M; Hattori Y; Ishimura M; Inaura S; Fujiwara D; Takatani-Nakase T; Fujii I; Futaki S; Kirihata M
    Chem Commun (Camb); 2019 Nov; 55(93):13955-13958. PubMed ID: 31617510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
    Yinghuai Z; Hosmane NS
    Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy].
    Nakamura H
    Yakugaku Zasshi; 2013; 133(12):1297-306. PubMed ID: 24292174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.